ゴナドトロピンを放出するホルモン受容体対抗薬
1Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, PO Box 7057, 1007MB, Amsterdam, Netherlands.
Lancet (London, England)
|December 6, 2001
まとめ
新しいGnRHアンタゴニストは, Gonadotropin Releasing Hormone (GnRH) の効果を即座に遮断し, 助産生殖やホルモン依存症に対する効果的な代替手段を提供します. これらのアンタゴニストは,治療期間とホルモンの使用を短縮する有望な効果を示しています.
科学分野:
- 生殖内分泌学 生殖内分泌学
- 薬理学 薬理学とは
背景:
- 脈動性GnRHは,下垂体LHとFSHの分泌を調節し,性腺機能を制御する.
- GnRHブロックは助産生殖および性ホルモン依存性疾患の治療に使用されます.
- 伝統的な方法には,GnRHアゴニストの無感化が含まれているが,GnRHアゴニストは即時ブロックを提供している.
研究 の 目的:
- 新しく開発されたGnRH受容体抗原剤の臨床的有用性と有効性を評価する.
- 様々な臨床応用において,GnRHアンタゴニストを既存のGnRHアゴニスト療法と比較する.
主な方法:
- GnRHアンタゴニストに関する臨床データのレビュー.
- 助産生殖と前立腺がんにおけるGnRHアンタゴニストとアゴニストの治療結果の比較.
主要な成果:
- GnRHアンタゴニストは,助産生殖における確立された治療法に匹敵する有効性を示しています.
- これらのアンタゴニストは,治療期間を短くし,ゴナドトロピンの使用を削減し,患者の受容性を改善します.
- 臨床的証拠は助産生殖と前立腺がんにおいて最も強く,子宮内膜症,子宮線維腫,乳がん,良性前立腺増殖,早発性青春期における潜在的な応用がある.
結論:
- GnRHアンタゴニストは,GnRHの作用を阻害する重要な進歩を表しています.
- 彼らは,さまざまな臨床的徴候において,GnRHアゴニストに対する有望で効果的な代替品を提供します.
- さらに臨床的証拠は,特に助産生殖と前立腺がんの管理において,その使用を支持しています.
さらに関連する動画
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
関連する概念動画
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...